SC
CELG

Steven Cohen’s Celgene Corp CELG Stock Holding History

Steven Cohen’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-100,000
Closed -$6.41M – 1357
2018
Q4 		$6.41M Buy
+100,000
New +$7.38M 0.03% 498
2018
Q2 		– Sell
-100,000
Closed -$8.92M – 1313
2018
Q1 		$8.92M Buy
+100,000
New +$9.6M 0.04% 450

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Steven Cohen's CELG Position: Q1 2019 in Review

Steven Cohen sold out of Celgene Corp (CELG) in Q1 2019, closing a stake of 1,651,513 shares — an estimated $106M sold.

Steven Cohen first reported a position in CELG in Q2 2014 and held it in 12 quarters. The position peaked at $106M in Q4 2018. 1,389 funds tracked by Wall St. Rank hold CELG as of Q1 2019.

  • Steven Cohen reported no remaining Celgene Corp position as of Q1 2019 after selling out during the quarter.
  • Steven Cohen sold 1,651,513 Celgene Corp shares in Q1 2019, an estimated $106M.
  • Steven Cohen first reported a position in Celgene Corp in Q2 2014 and held it in 12 quarters.
  • Steven Cohen's Celgene Corp position peaked at $106M in Q4 2018.
  • 1,389 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2019.

Based on Point72 Asset Management's 13F filing for Q1 2019, filed 15 May 2019.